Can Fite Biopharma Ltd (CANF) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Can fite Biopharma Ltd   (NYSE: CANF)


Can Fite Biopharma Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Can Fite Biopharma Ltd's ROI in the fourth quarter of 2025?
Can Fite Biopharma Ltd recorded a cumulative net loss of $-10 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -187.56%.

Within the Healthcare sector 845 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 4264 to 4876.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 11.57 % 6.18 % -9.97 % -30.43 % -34.22 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 6 6 4 6 5
Return On Investment (TTM) -187.56 % -151.51 % -152.65 % -166.39 % -167.78 %
CANF's Overall Ranking # 4876 # 4264 # # #
Seq. Investment Change TTM 0.75 % 0.76 % 9 % 0.83 % -4.12 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -8 -8 -8 -8

CANF Company Profile >> Back to CANF Roi Comparisons >> See Annual CANF Return On Investment



Return On Investment CANF's Ranking
Within: No.
Industry # 396
Sector # 846
Overall # 4876

Return On Investment Statistics
High Average Low
-57.21 %
-131.89 %
-175.28 %
(Dec 31 2021)   (Dec 31 2025)







Financial Statements
Can Fite Biopharma Ltd's IV. Quarter Investments $ 6 Millions CANF's Balance sheet
Can Fite Biopharma Ltd's IV. Quarter Income $ -10 Millions Quarterly CANF's Income Statement
CANF's Income by Division See CANF's Income by Division


CANF Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 6 5 6 7 17
Y / Y Investment Growth 2.87 % -12.93 % -7.83 % -61.19 % 112.05 %
Net Income in Millions -10 -8 -8 -10 -10
Y / Y Net Income Growth - - - - -
Annual Return On Investment -175.75 % -144.96 % -122.28 % -150.2 % -57.44 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CANF's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CANF's Competitors
Subscribers only: Roi for Can Fite Biopharma Ltd's Suppliers
Subscribers only: Return On Investment for CANF's Customers

Other Ratios
CANF's Roa CANF's Inventory Turnover Ratio CANF's Growth Rates CANF's Dividend Statistics
CANF's Profitability Ratios CANF's Asset Turnover Ratio CANF's Dividend Growth
CANF's Roe CANF's Valuation Ratios CANF's Financial Strength Ratios CANF's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.